AASP

ACPE Program #:       0485-0000-23-003-L04-P (1.0 Contact Hour)
ACPE Activity Type:    Application

Moderator:     Susan Davis, PharmD
Facilitator:      Jacinda Abdul-Mutakabbir, PharmD, MPH

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Describe the relationship between systemic racism, social determinants of health, and the treatment of patients with infections
2. Identify factors in antimicrobial stewardship processes and policies that could result in disparities in care
3. Develop a strategy to evaluate and reduce health disparities in antimicrobial use in individual practice settings

ACPE Program #:        0485-0000-23-004-L01-P (1.0 Contact Hour)
ACPE Activity Type:     Application

Moderator:      Mike Rybak, PharmD, MPH, PhD
Facilitator(s):   Kate DeSear, PharmD and Veena Venugopalan, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Identify patients who may benefit from BL TDM
2. List potential barriers and opportunities for implementation of a BL TDM service
3. Develop a workflow for beta-lactam TDM

ACPE Program #:        0485-0000-23-005-L04-P (1.0 Contact Hour)
ACPE Activity Type:     Application

Moderator:      David Ha, PharmD
Facilitator:       Mary Hutton, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Outline the unique and diverse challenges faced by antibiotic stewards in community hospital settings
2. Discuss approaches to launch or expand an antibiotic stewardship program in a community hospital
3. Identify practical strategies to apply in your practice setting

1. Discuss evidence-based educational techniques and their application to infectious diseases education
2. Identify best practices for infectious diseases education in didactic and experiential settings
3. Apply best practices in creation of a chalk talk 

ACPE Program #:       0485-0000-23-007-L04-P (1.0 Contact Hour)
ACPE Activity Type:    Application

Moderator:       Kerry LaPlante, PharmD
Facilitator:        Rebekah Moehring, MD, MPH

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Describe behavioral and social factors impacting stewardship collaboration in ICUs
2. Identify high priorities for antibiotic optimization in ICU settings
3. (Application based activity) Design a plan for improving antimicrobial stewardship in an intensive care setting

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Explain factors contributing to inappropriate antibiotic use in outpatient settings
2. Identify resources to promote safe antimicrobial use in routine outpatient practice
3. Demonstrate strategies to engage patients, caregivers, or prescribers about safe antibiotic use

Learning Objectives:
Upon completion of this session, the participant will be able to

1. List potential barriers to implementing GN treatment guidance
2. Identify resources-collaborators for successful implementation of GN guidance
3. Describe methods for documenting outcomes post implementation of GN guidance 

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Define diagnostic stewardship and how it is interconnected with antibiotic stewardship
2. Outline strategies for antibiotic stewardship programs to collaborate with clinical laboratories on diagnostic stewardship efforts
3. Describe how to demonstrate impact of diagnostic stewardship interventions 

ACPE Program #:        0485-0000-23-011-L04-P (1.0 Contact Hour)
ACPE Activity Type:     Knowledge

Moderator:       Kerry LaPlante, PharmD
Speaker:          Lauri Hicks, DO

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Discuss clinical, social, and regulatory factors impacting future antibiotic use and resistance trends
2. Forecast emerging antimicrobial stewardship priorities in health equity, and strategies for institutional and community settings
3. Describe a framework for combatting emerging antimicrobial resistance threats in the future

AASP

ACPE Program #:         0485-0000-23-012-L01-P (1.5 Contact Hours)
ACPE Activity Type:      Knowledge

Moderator:      Susan Davis, PharmD

Plenary 1A      Oral Antibiotics as Stepdown for Serious Infections Speaker:           Erin McCreary, PharmD

Plenary 1B       Advances in De-escalation
Speaker:           Rebekah Moehring, MD, MPH

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Define de-escalation in terms of spectrum, route, and duration of therapy
2. Describe the evidence to support oral antibiotics as stepdown therapy for serious infections including bacteremia and bone and joint infection
3. Explain successful approaches to optimize duration of antimicrobial therapy

AASP

ACPE Program #:         0485-0000-23-013-L04-P (1.5 Contact Hours)
ACPE Activity Type:      Knowledge

Moderator:       Mike Rybak, PharmD, MPH, PhD

Plenary 2A       New Antibiotic Development
Speaker:           George Sakoulas, MD

Plenary 2B       Advances in Immunomodulatory Therapies
Speaker:           Dave Feola, PharmD, PhD

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Describe the gaps in antibiotic and immunomodulatory therapy development
2. List and describe the novel antibiotic and immunomodulatory therapies
3. Identify the potential patients who would benefit from novel antibiotic and immunomodulatory therapy

AASP

Plenary 3A      What’s Hot in Bugs & Drugs:  Update on Treatment of Non-fermenters
Speaker:          Sam Aitken, PharmD, MPH

Plenary 3B      Expert Opinion:  Evaluating Therapeutic Gaps in the Guidelines/
Making Recommendations When the Evidence is Gray
Speaker:           Meghan Jeffres, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. List the problematic non-fermenter GN pathogens
2. Describe the latest recommendations for the treatment of GN non-fermenters
3. Identify the therapeutic gaps in guidelines associated with treatment of Staphylococcus aureus infection, focus on bone and vascular infections
4. Fill the guideline gaps about the treatment of Staphylococcus aureus infections with primary literature

AASP

ACPE Program #:         0485-0000-23-015-L04-P (1.5 Contact Hours)
ACPE Activity Type:      Knowledge

Moderator:      David Ha, PharmD

Plenary 4A     MIC, ECOFFs, and Breakpoints; What do I Need to Know as a Clinician?
Speaker:         Kerry LaPlante, PharmD

Plenary 4B     Different Organizations, Different Breakpoints:  Making Sense of Recent Updates to Susceptibility Breakpoints from CLSI, EUCAST, and USCAST
Speaker:          Jason Pogue, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Discuss the history, development, and utility of Antimicrobial Susceptibility Testing methodologies
2. Evaluate practical applications and impact of breakpoints and MICs in common clinical scenarios
3. Describe the approaches used to develop susceptibility interpretive criteria in different agencies (e.g. CLSI, FDA, USCAST, EUCAST)

AASP

ACPE Program #:       0485-0000-23-016-L04-P (1.5 Contact Hours)
ACPE Activity Type:      Knowledge

Moderator:       Susan Davis, PharmD

Plenary 5A       Next Generation Technologies in ID Diagnostics
Speaker:           Jose Alexander, MD, D(ABMM), SM, MB(ASCP)

Plenary 5B       Point of Care Testing in Outpatient Care
Speaker:           Mike Klepser, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Identify emerging technologies for rapid microbial identification and susceptibility testing in inpatient and outpatient settings
2. Describe the impact of new diagnostic technologies on antimicrobial use, patient outcome, and access to care
3. Explain collaborative approaches for implementation of point of care testing in outpatient settings

AASP

Moderator:       David Ha, PharmD

Plenary 6A      The Team: Collaborating with Internal Medicine and Other Teams to Improve Antibiotic Use
Speaker:           Valerie Vaughn, MD, MS

Plenary 6B       Bringing People Together Across the Team:  Patient Advocate,
Patient Experiences
Speakers:         Christian Lillis

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Describe the importance of collaboration between antibiotic stewardship programs and internal medicine and other clinicians
2. Identify practical strategies for antibiotic stewardship programs to collaborate with internal medicine and other clinicians
3. Describe the patient perspective on consequences of antibiotic misuse and the importance antibiotic stewardship

AASP

ACPE Program #:         0485-0000-23-018-L04-P (1.5 Contact Hours)
ACPE Activity Type:      Knowledge

Moderator:      David Ha, PharmD

Plenary 7A      Immunization Stewardship
Speaker:          Michael Hogue, PharmD

Plenary 7B      Microbiome Stewardship and Live Biological Products Role in Prevention of Infectious Diseases
Speaker:           Sahil Khanna, MBBS,MS

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Outline recent updates to CDC ACIP vaccine recommendations and their supporting clinical evidence
2. Discuss the importance of the microbiome and fecal microbiota transplantation in prevention of infectious diseases
3. Describe the role of live biological products in the prevention of Clostridioides difficile infection

Moderator:       Kerry LaPlante, PharmD

Plenary 8A/8B  Hot Topics: What Did You Miss in Infectious Diseases 2022-2023
Speaker(s): Jason Pogue, PharmD and Erin McCreary, PharmD

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. Identify major developments published in the ID literature from May 2022 thru March 2023
2. Summarize important, new clinical studies or guidelines impacting antimicrobial use
3. Discuss preliminary findings of key unpublished studies that were presented at recent ID conferences

Facilitator:        Mike Rybak, PharmD
Panelists:          TBA

Learning Objectives:
Upon completion of this session, the participant will be able to:

1. List the top 5 antimicrobial therapy controversies of 2023
2. Identify a therapeutic intervention associated with multidrug resistant pathogens
3. Describe an antimicrobial stewardship issue that directly relates to your specific practice/institution